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University of Debrecen, Debrecen, HungaryABSTRACT Classical theory states that ligand binding induces the dimerization of ErbB proteins, leading to their activation.
Although we and other investigators have shown the existence of preformed homoclusters of ErbB receptors and analyzed their
composition, the stoichiometry of their heteroclusters has not been quantitatively described. Here, we report the development of
the ﬂuorescence resonance energy transfer (FRET)-sensitized acceptor bleaching (FSAB) technique to quantitate the ratio of
ErbB1 and ErbB2 in their heteroclusters. In FSAB, photolabile acceptors within FRET distance from photostable donors are
excited and photobleached by FRET, and the fraction of acceptors that are participating in FRET is determined. In quiescent
SKBR-3 breast cancer cells, ~35% of ErbB1 and ~10% of ErbB2 have been found in heteroclusters. Epidermal growth factor
(ligand of ErbB1) increased the fraction of ErbB2 heteroclustering with ErbB1, whereas the ratio of heteroclustered ErbB1 did
not change signiﬁcantly. The fractions of heteroclustered ErbB1 and ErbB2 were independent of their expression levels, indi-
cating that the formation of these clusters is not driven by the law of mass action. In contrast, the FRET efﬁciency depended
on the donor/acceptor ratio as expected. We present a model in which preformed receptor clusters are rearranged upon ligand
stimulation, and report that the composition of these clusters can be quantitatively described by the FSAB technique.INTRODUCTIONThe fact that the association of cell surface receptors and
their activation are linked was established a long time ago,
and it has become a paradigm of receptor biology (1).
ErbB proteins are the best characterized of the receptor tyro-
sine kinases (RTK), but most published results describe their
associations in a qualitative way. Four ErbB proteins
(ErbB1–4) have been characterized and shown to form an
extensive network of homo- and heteroassociations (2).
Except for ErbB2, the extracellular domains of ErbB proteins
are thought to be in a tethered, inactive conformation that is
rearranged upon ligand binding, leading to exposure of the
dimerization arm. These events culminate in the formation
of ligand-induced homo- and heterodimers and receptor acti-
vation (1,3). Dimerization of the intracellular kinase domain
is directly involved in its activation, leading to the phosphor-
ylation of several tyrosine residues in the C-terminus and
recruitment of SH2 domain-containing proteins (2–4).
ErbB2 is at the heart of the association pattern because its
extracellular domain constantly assumes a conformation
that is capable of forming heterodimers (5). The signaling
potency of such heterodimers is significantly enhanced
compared to that of homodimers (6). Although information
derived from crystal structures of the ErbB2 extracellular
domain does not support the formation of ErbB2 homo-
dimers, the existence of overexpression-driven, ligand inde-
pendent ErbB2 homoassociations is supported by strong
experimental evidence (7).Submitted December 10, 2009, and accepted for publication March 31,
2010.
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0006-3495/10/07/0105/10 $2.00Molecular clusters can be characterized by a multitude of
techniques, including crystallography, several molecular
biological approaches, the proximity ligation assay, and the
VeraTag assay (8,9). Because of its quantitative nature and
relative ease of implementation, fluorescence resonance
energy transfer (FRET) has become the technique of choice
in quantitative studies of receptor clustering (10–12). In
hetero-FRET, an excited donor passes its energy to a spectro-
scopically different acceptor. The fact that the energy
transfer process in hetero-FRET is unidirectional limits its
sensitivity for distinguishing between clusters with more
than two subunits. Although dimers are unquestionably the
best-characterized type of receptor clusters, they are obvi-
ously not the only kind. Tetramers and even larger clusters
of ErbB1 have been detected by fluorescence correlation
spectroscopy (13,14). Very large clusters of ErbB2 and
ErbB3 involving tens or hundreds of proteins on a scale of
tens or hundreds of nanometers have been detected by elec-
tron (15) and near-field optical microscopy (16). Homo-
FRET involving the interaction between spectroscopically
identical fluorophores can also be used to detect the forma-
tion of large-scale homoclusters (17). Using flow cytometric
homo-FRET measurements, we have shown that the number
of monomers in an ErbB1 homocluster increases from ~4
to ~10 upon epidermal growth factor (EGF) stimulation.
ErbB2 was found to behave in the opposite way, in that it
formed extensive, large-scale clusters (~50–100 proteins/
cluster) in the absence of stimulation, which decreased in
size after treatment with EGF or neuregulin (18). Although
the stoichiometry of large-scale heteroclusters could not be
measured, we hypothesized that ligand-bound ErbB1 and
ErbB3 recruits ErbB2 to heterodimers, leading to thedoi: 10.1016/j.bpj.2010.03.061
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number and brightness (N&B) measurements and two-color
fluorescence correlation, investigators may be able to deter-
mine the stoichiometry of heteroclusters by measuring the
comobility of different receptors (19–21).
In this study, we developed and used a technique origi-
nally proposed by Mekler et al. (22,23) to characterize the
composition of heteroclusters of ErbB1 and ErbB2 in a quan-
titative way. Briefly, FRET from a photostable donor to
a photolabile acceptor induces acceptor photobleaching.
Optimally, only acceptors within FRET distance from
donors will undergo photobleaching. Using this approach,
which we call FRET-sensitized acceptor bleaching
(FSAB), the fraction of acceptors within FRET distance
from donors can be quantitatively determined. We demon-
strate that FSAB can principally be used to determine the
fraction of acceptors within FRET distance of donors by
showing that the efficiency of FRET drops to zero long
before all acceptor molecules are bleached, using Alexa-
Fluor546-Cy5 as a donor-acceptor pair. In quiescent
SKBR-3 breast tumor cells, only ~10% of ErbB2 heteroasso-
ciates with ErbB1, and this fraction is doubled by EGF
stimulation. Although a higher fraction of ErbB1 forms het-
eroclusters with ErbB2, this fraction is not significantly
changed by EGF treatment. The FSAB technique is suitable
for measuring the heteroclustering of proteins in a quantita-
tive way, and has the potential to provide new insight into the
behavior of receptor tyrosine kinases upon activation.MATERIALS AND METHODS
Cells and reagents
SKBR-3 breast cancer and A431 epithelial carcinoma cell lines were
obtained from the American Type Culture Collection (ATCC, Manassas,
VA) and grown according to the their specifications. For microscopic exper-
iments, cells were grown in two- or eight-well chambered coverglasses
(Nalge Nunc International, Rochester, NY). ErbB1 and ErbB2 were labeled
by Mab528 and trastuzumab, respectively. Mab528 was purified from the
supernatant of the HB-8509 hybridoma cell line (ATCC) by protein A
affinity chromatography. Trastuzumab (Herceptin) was purchased from
Roche Ltd. (Budapest, Hungary). Conjugation of antibodies with
AlexaFluor (Molecular Probes, Eugene, OR), Cy5 (GE HealthCare, Frei-
burg, Germany), or Qdot605 (Invitrogen, Karlsruhe, Germany) was carried
out according to the manufacturers’ specifications. The number of fluoro-
phores on a single antibody was determined by spectrophotometry and
was always kept between 1–2 to reduce the possibility of interactions
between neighboring Cy5 molecules (24). EGF and CBr4 were purchased
from R&D Systems (Minneapolis, MN) and Sigma-Aldrich (Schnelldorf,
Germany), respectively.Stimulation and labeling of cells
SKBR-3 cells grown in chambered coverglass were starved in medium con-
taining 0.1% fetal calf serum for 24 h before experiments were conducted,
and stimulated by 100 nM EGF in Hank’s buffer supplemented with
1 mg/mL bovine serum albumin for 15 min at 37C. Control and stimulated
cells were labeled by a saturating concentration (10–20 mg/mL) of fluores-
cent Mab528 and/or trastuzumab in Hank’s buffer containing 1 mg/mLBiophysical Journal 99(1) 105–114bovine serum albumin for 30 min on ice. Unbound antibodies were removed
by washing twice in phosphate-buffered saline, and cells were fixed in 1%
formaldehyde.Confocal microscopy and photobleaching
A Zeiss LSM 510 confocal laser scanning microscope (Carl Zeiss AG, Jena,
Germany) was used to image the samples. AlexaFluor546 was excited at
543 nm and its emission was detected at 560–615 nm. The fluorescence
of Cy5 was excited at 633 nm and detected above 650 nm. When FRET
between Alexa546 and Cy5 was measured, a third fluorescence image
(FRET channel), excited at 543 nm and recorded above 650 nm, was also
measured in addition to the donor (AlexaFluor546) and acceptor (Cy5) chan-
nels. Qdot605 was excited at 488 nm and its emission was recorded at 585–
615 nm. Fluorescence images were taken as single optical sections using
a 63x (NA ¼ 1.4) oil immersion objective focused to the middle of the
cell along the Z axis. The pinhole size was adjusted to 2 Airy units. The
image size was 512512 pixels, and the pixel size in the X and Y directions
was 400 nm. To induce FRET-sensitized bleaching of Cy5, the sample was
illuminated at 543 nm (bleaching beam). Bleaching illumination was inter-
rupted approximately every 30 s, and donor, FRET, and acceptor images
were recorded with an attenuated laser beam. The power of the 543 nm laser
line was set to 5% and 100% for the imaging and bleaching illuminations,
respectively. Photobleaching was carried out in the presence of 8104
M CBr4.Image analysis
Image processing was carried out with the DipImage toolbox (Delft
University of Technology, Delft, The Netherlands) under MATLAB (The
MathWorks Inc., Natick, MA). Segmentation of images into membrane
and nonmembrane pixels was carried out with the manually seeded water-
shed algorithm using a custom-written MATLAB program (25,26). Image
stacks acquired during photobleaching were corrected for shift using the cor-
rectshift command of DipImage. FRET efficiency, unquenched donor and
direct acceptor intensities corrected for spectral overspill were calculated
in the photobleaching stack in the membrane of selected cells double-labeled
by donor- and acceptor-tagged antibody as described previously (27), and
the fraction of bleached acceptors (Fbleached in Eq. 5) was determined at
the time when the FRET efficiency dropped to zero. The fraction of directly
bleached acceptors excited at the excitation wavelength of the donor (BCF in
Eq. 5) was determined using a sample labeled with acceptor only.
To calibrate the donor and acceptor fluorescence intensities in terms of the
number of molecules, two samples of SKBR-3 cells were separately labeled
by either the donor- or acceptor-tagged antibody against the same epitope.
The means of the background-corrected fluorescence intensities in the
membrane of ~100 cells were determined separately in the donor-only and
acceptor-only labeled samples (hIdi and hIai, respectively), and corrected
for labeling ratio, i.e., the number of fluorophores per antibody. Since the
cells in the two samples contained on average the same number of antibodies
per cell, the ratio of the mean fluorescence intensities is the ratio of the fluo-
rescence intensities generated by the same number of fluorophores in the
donor and acceptor channels:
Ra=d ¼ hIaihIdi
Ld
La
(1)
where Ld and La are the number of fluorophores on the donor- and acceptor-
labeled antibodies, respectively. The fluorescence intensity in the donor
image of double-labeled cells was multiplied by Ra/d to ensure that the donor
and acceptor fluorescence intensities would be on the same scale. To cali-
brate these fluorescence intensities in terms of receptor numbers, the number
of binding sites of the respective antibody was determined by flow cytome-
try using Qifikit (DAKO, Hamburg, Germany). Briefly, a series of beads
with calibrated numbers of bound primary mouse monoclonal antibodies
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rescence intensity of blank beads, a calibration curve was constructed from
which the slope and y-intercept were determined. The cells were labeled by
primary mouse monoclonal antibodies against the antigen of interest, fol-
lowed by secondary labeling by the fluorescent secondary antibody used
to label the beads, and flow cytometric determination of their fluorescence
intensity. After background correction was performed, the number of anti-
gens on the investigated cell line was determined by linear regression.
The number of molecules was then calculated for the microscopic images
according to the following equation:
Ni ¼ IihIiNQifi (2)
where Ni and NQifi are the number of molecules in a given cell or pixel and
the mean number of molecules in the population of cells determined by
Qifikit, respectively, and Ii and hIi are the fluorescence intensity in a given
cell or pixel and the mean fluorescence intensity of the population of cells
corrected by Ra/d, respectively.THEORY
Determination of the fraction of bound acceptors
Given a photostable FRET donor and an acceptor that is sensi-
tive to a photochemical reaction, one can determine the FRET
efficiency according to the enhanced rate of the photochem-
ical reaction of the acceptor excited at the wavelength of the
donor (22). Mekler et al. (23) claimed that even small FRET
efficiencies can be accurately determined using this approach,
which explains why the technique is called photochemical
enhancement of sensitivity (PES). If the photochemical reac-
tion of the acceptor is irreversible photobleaching, then FRET
results in the accelerated rate of acceptor photobleaching. To
emphasize that our approach is based on the enhanced rate of
acceptor photobleaching as a result of FRET, we coined the
term ‘‘FRET-sensitized acceptor bleaching’’ (FSAB). Since
acceptors that take part in FRET are preferentially bleached,
it is possible to calculate the relative contribution of the
bleached acceptor subpopulation to the total FRET efficiency
by analyzing the relationship between the decays of FRET
efficiency and sensitized acceptor emission (23). We were
interested in the theoretical endpoint of FSAB, i.e., the point
at which all acceptors within FRET distance from donors are
bleached. We assumed that two classes of acceptors exist with
regard to their association with donors: 1) acceptors bound to
donors, i.e., within FRET distance from donors (Abound); and
2) free acceptors (Afree). When all of the bound acceptors are
bleached, the FRET efficiency has to drop to zero. By
comparing the acceptor intensity (proportional to the number
of acceptors) at the time point when FRET drops to zero with
the total acceptor intensity before the FSAB process is under-
taken, one can determine the fraction of bound acceptors
(Abound/A0). Because acceptors are also excited directly at
the wavelength of the donor, some free acceptor molecules
outside the range of FRET are also bleached. The bleached
fraction of Afree (at the time of complete bleaching of Abound,
i.e., when FRET decreases to zero) is designated the bleaching
correction factor (BCF). Therefore, the fraction of bleachedacceptors (Fbleached) and Abound can be calculated according
to the following equations:
Fbleached ¼ Afree BCF þ Abound
Afree þ Abound (3)
Abound þ Afree ¼ A0 (4)
Solving for Abound yields
Abound ¼ A0Fbleached  BCF
1  BCF (5)
Since BCF was found to vary between different antibodies, it
had to be determined for every individual labeled batch of
any acceptor-conjugated antibody used in the FSAB experi-
ments. To reduce the effects of the possible intensity depen-
dence of Cy5 photobleaching arising from the interactions
between neighboring Cy5 molecules (24), BCF was deter-
mined on cells with fluorescence intensities similar to those
of double-labeled cells used for the FSAB experiments. It is
assumed in Eqs. 3–5 that 100% of the bound acceptor pop-
ulation is bleached. However, as discussed later, the bleach-
ing of Cy5, the acceptor chosen for FSAB measurements,
may not always be complete. If the bleached fraction of
the bound acceptor population is designated by BCFFRET,
the fraction of bound acceptors can be calculated according
to the following equation:
Fbleached ¼ Afree BCF þ Abound BCFFRET
Afree þ Abound 0
Abound ¼ A0 Fbleached  BCF
BCFFRET  BCF ð6Þ
BCFFRET can be determined with a sample labeled with Cy5-
conjugated primary antibody followed by labeling with an
AlexaFluor546-tagged secondary antibody.RESULTS
Selection of an appropriate donor-acceptor pair
for FSAB experiments
The prerequisite for successful application of the FSAB tech-
nique is a donor-acceptor FRET pair in which the donor is
photostable and the acceptor is photolabile. Although Cy5
is known to be relatively photolabile in confocal microscopy,
the time required for its complete bleaching is prohibitively
long. In accordance with the results of Mekler et al. (22,23),
we found that CBr4 significantly accelerated the rate of pho-
tobleaching of Cy5 (see Fig. S1 in the Supporting Material).
A donor that would be photostable in the presence of CBr4
had to be found. Quantum dots were obvious candidates
because of their known photostability, but CBr4 significantly
enhanced the rate of their photobleaching (Fig. S1).Biophysical Journal 99(1) 105–114
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the absence and presence of CBr4, and therefore we used it
as a donor for Cy5 in the FSAB experiments.
We measured the kinetics of Cy5 photobleaching at
633 nm (the excitation wavelength for Cy5) and at 543 nm
(the excitation wavelength for AlexaFluor546). Photo-
bleaching of Cy5 at 543 nm was incomplete, i.e., a residual
fluorescence intensity amounting to 20–40% of the initial
intensity was resistant to bleaching when the intensity was
measured at 543 or 633 nm (Fig. S2 A). On the other
hand, the photobleaching of Cy5 at 633 nm was complete
independent of whether the images were recorded at an exci-
tation wavelength of 543 or 633 nm (Fig. S2 A).Proof of concept: the FSAB technique reliably
detects receptor clusters
We first established theoretically the reliability of the FSAB
approach using AlexaFluor546 and Cy5 dyes. We show in
the Supporting Material that although the acceptor is photo-
bleached both directly and via the donor, the fraction of bound
acceptors can be reliably determined. In addition, donor
bleaching does not have a significant effect on the value for
the fraction of bound acceptors calculated by FSAB
(Fig. S3). Next, we tested the FSAB approach using a positive
and a negative control. It was previously shown that the
majority of ErbB1 is monomeric, with a minority forming
small aggregates in nonstimulated cells. On the other hand,
the majority of ErbB2 forms large clusters in quiescent cells
(18). We compared the photobleaching kinetics of Cy5 in
SKBR-3 cells labeled with a 1:1 mixture of Cy5-conjugatedFIGURE 1 Decrease of FRET efficiency and acceptor fluorescence during FS
using FSAB. A431 cells were labeled with Cy5-Mab528 (C) or with a mixture of
with Cy5-trastuzumab (;) or with a mixture of Cy5-trastuzumab and AlexaFluor5
CBr4 at 543 nm. The directly excited acceptor fluorescence intensities are shown
for every third data point for clarity. (B) Determination of the fraction of heteroclu
EGF-stimulated SKBR-3 cells were labeled with a mixture of AlexaFluor546-tras
sitized, directly excited acceptor fluorescence and the FRET efficiency were calc
channels when the bleaching illumination was interrupted at the excitation wave
cells; B, FRET efficiency of nonstimulated cells;-, directly excited acceptor
cells). Photobleaching was carried out in the presence of CBr4. Error bars indicat
clustered ErbB2 in the absence and presence of EGF stimulation. SKBR-3 cells w
Otherwise, the experimental conditions and symbol assignments are the same as
Biophysical Journal 99(1) 105–114and unlabeled antibodies against ErbB2 or with a 1:1 mixture
of AlexaFluor546-tagged and Cy5-tagged anti-ErbB2 anti-
bodies. Unlabeled antibodies were used to reduce the binding
of the Cy5-conjugated antibody to levels comparable to those
found in donor-acceptor double-labeled samples, to prevent
artifacts arising from the possible influence of interactions
between Cy5 molecules on the photobleaching kinetics
(24). In accordance with the results shown in the previous
section, Cy5 was incompletely bleached in cells labeled
only with Cy5-tagged antibodies (Fig. 1 A). However, its
bleaching was practically complete by the second bleaching
step, when the FRET donor was present, and the FRET effi-
ciency dropped to zero at this time point (data not shown).
For quantitative evaluation of the fraction of homoclustered
ErbB2, we used the fluorescence intensities measured after
two bleaching steps because the FRET efficiency dropped
to zero at this time point. Substitution into Eq. 5 yielded
83% for the fraction of homoclustered ErbB2 (Fig. 2A). Since
the expression level of ErbB1 is much higher in A431 cells
than in SKBR-3 cells, and previous experiments by our group
(18) and others (14,28) to measure the homoassociation of
ErbB1 were carried out in A431 cells, we used this cell line
to compare the results of our previous homo-FRET experi-
ments with those obtained using the FSAB approach. The
photobleaching kinetics of Cy5 in cells labeled with a 1:1
mixture of Cy5-conjugated and unlabeled monoclonal anti-
bodies against ErbB1 was comparable to that measured in
cells labeled with a 1:1 mixture of AlexaFluor546-tagged
and Cy5-tagged anti-ErbB1 antibodies (Fig. 1 A). This obser-
vation implies that the majority of ErbB1 is nonclustered.
A quantitative comparison of the two curves reveals thatAB. (A) Determination of the fraction of homoclustered ErbB1 and ErbB2
Cy5-Mab528 and AlexaFluor546-Mab528 (B). SKBR-3 cells were labeled
46-trastuzumab (6), and the samples were photobleached in the presence of
in the graph. Error bars indicating the mean5 standard error (SE) are shown
stered ErbB1 in the absence and presence of EGF stimulation. Quiescent and
tuzumab and Cy5-Mab528 against ErbB2 and ErbB1, respectively. Nonsen-
ulated by recording fluorescence images in the donor, FRET, and acceptor
length of the donor (,, directly excited acceptor intensity of nonstimulated
intensity of EGF-stimulated cells;C, FRET efficiency of EGF-stimulated
e the mean5 SE of ~100 cells. (C) Determination of the fraction of hetero-
ere labeled with a mixture of AlexaFluor546-Mab528 and Cy5-trastuzumab.
in B.
FIGURE 2 The fraction of homo- and heteroclus-
tered ErbB1 and ErbB2 in quiescent and EGF-stim-
ulated SKBR-3 cells determined by FSAB. (A)
Determination of the fraction of homoclustered
ErbB1 and ErbB2 in quiescent and stimulated
SKBR-3 cells. Starved (black columns) and EGF-
stimulated (gray columns) A431 cells were labeled
with a mixture of Cy5-tagged and AlexaFluor546-
tagged Mab528 (to measure the homoclustering of
ErbB1). Starved (black columns) and EGF-stimu-
lated (gray columns) SKBR-3 cells were labeled
with Cy5-conjugated and AlexaFluor546-conju-
gated trastuzumab (to measure the homoclustering
of ErbB2), and the fraction of homoclustered
acceptor was determined using FSAB. Error bars
indicate the mean5 SE of ~100 cells. (B) Determi-
nation of the fraction of heteroclustered ErbB1 and
ErbB2 in starved and EGF-stimulated SKBR-3
cells. The fraction of ErbB1 molecules forming het-
eroclusters with ErbB2 was calculated by labeling
SKBR-3 cells with a mixture of AlexaFluor546-
trastuzumab and Cy5-Mab528 against ErbB2 and
ErbB1, respectively. The fraction of ErbB2 hetero-
associating with ErbB1 was determined by labeling cells with AlexaFluor546-Mab528 and Cy5-trastuzumab. The fractions of free/homo- and heteroclustered
molecules were converted to absolute numbers after determining the expression levels of ErbB1 and ErbB2. The numbers of heteroclustered and free/homo-
clustered molecules are shown by the black and gray parts of the bars, respectively, in quiescent and EGF-stimulated cells. The FSAB approach only char-
acterizes whether an acceptor is heteroassociated with a donor; therefore, a free acceptor may indeed be a free (i.e., monomeric) molecule or form homoclusters
or heteroclusters with other molecules.
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fraction of homoclustered ErbB1 in EGF-stimulated A431
cells was ~3-fold higher than in starved cells (Fig. 2 A).
However, the fraction of heteroclustered ErbB2 decreased
upon EGF stimulation in SKBR-3 cells (Fig. 2 A). The frac-
tions of homoclustered ErbB1 and ErbB2 in starved and
EGF-stimulated cells determined by the FSAB technique
are in agreement with previous results obtained by homo-
FRET (18).
Since the duration of bleaching is long in FSAB experi-
ments (~200 s), we tested whether protein mobility would
affect the results of our experiments. As shown in Fig. S4,
the lateral mobility of ErbB1 is abolished in formaldehyde-
fixed cells. Therefore, we concluded that only proteins
associated with each other at the time of fixation are detected
by the FSAB approach, i.e., those acceptors that would
transiently associate with donors (if they were free to diffuse)
are not counted as bound. Since heteroclusters cannot
be analyzed by homo-FRET measurements, we set out to
characterize the heteroassociation of ErbB1 and ErbB2 using
the FSAB approach. Since SKBR-3 cells express both ErbB1
and ErbB2 at moderate to high levels (~2105 ErbB1 and
~106 ErbB2; values determined by Qifikit), and ErbB2 is
only slightly expressed by A431 cells (~2106 ErbB1 and
~2104 ErbB2), we chose to use SKBR-3 cells for these
experiments. Cells were labeled with AlexaFluor546-tagged
antibody against ErbB2 and Cy5-tagged antibody against
ErbB1, and the directly excited fluorescence intensity of
the acceptor and the FRET efficiency were calculated after
each bleaching step (Fig. 1 B). In accordance with the afore-mentioned results, the FRET efficiency dropped to zero after
the second bleaching step, indicating that all acceptors within
FRET distance of the donors were bleached (Figs. 1 B, 2 B,
and 3). However, the fluorescence intensity of the acceptor
was only reduced to ~35% of the initial value, indicating
that a significant fraction of the acceptor was not within
FRET distance of the donors (Figs. 1 B and 2 B). The
labeling ratio (number of fluorophores per antibody) is ex-
pected to influence the initial value of FRET, but as long
as the starting FRET efficiency is not too small, acceptors
within FRET distance from the donors will be bleached.
The extent of bleaching of donor fluorescence was much
smaller than that of the acceptor or the fractional decrease
in the FRET efficiency (Fig. 3). A quantitative evaluation ac-
cording to Eq. 5 revealed that ~40% of the acceptor (ErbB1)
was heteroclustered with the donor (ErbB2). To obtain repro-
ducible results, we only analyzed cells with bright
fluorescence in which FRET decreased monotonously with
bleaching and could be reliably determined, and in which
the fraction of bleachable acceptors in the double-labeled
sample was at least 90%. We concluded that the fraction of
heteroclustered proteins can be reliably determined by the
FSAB technique, and started a systematic investigation of
ErbB1 and ErbB2 in quiescent and stimulated cells.Quantitative analysis of heteroclusters of ErbB1
and ErbB2 in quiescent and EGF-stimulated cells
SKBR-3 breast cancer cells were starved in the presence
of 0.1% fetal calf serum for 24 h and labeled withBiophysical Journal 99(1) 105–114
FIGURE 3 Representative images for calculating the fraction of bound acceptors using the FSAB technique. SKBR-3 cells were labeled with Alexa546-
Mab528 and Cy5-trastuzumab, and the fraction of bound acceptors was analyzed by the FSAB approach. (A) The image recorded in the acceptor channel
to which the manually seeded watershed segmentation algorithm was applied to segment the image into membrane and nonmembrane pixels. (B) The
membrane mask (in red) overlaid on the fluorescence image shown in A. (C and D) Unquenched donor fluorescence intensity calculated for membrane pixels
before the beginning of bleaching (C) and after the second bleaching step, corresponding to ~200 s of photobleaching (D). (E and F) The FRET efficiency
calculated before bleaching (E) and after the second bleaching step (F). Pixels are color-coded according to the FRET efficiency, which ranges between
0 and 30%. (G and H) Nonsensitized acceptor emission calculated before bleaching (G) and after the second bleaching step (H). The fluorescence images
(C, D, G, and H) were contrast-stretched, and therefore the donor (C and D) and acceptor fluorescence intensities (G and H) are not comparable.
110 Szabo´ et al.AlexaFluor546-tagged antibody against ErbB1 and Cy5-
tagged antibody against ErbB2. The fraction of ErbB2 heter-
oclustering with ErbB1 in these nonstimulated cells was
found to be 10%. After EGF stimulation, ErbB2 was re-
cruited into heteroclusters with ErbB1, which was reflected
by an ~2-fold increase in the fraction of ErbB2 heteroassoci-
ating with ErbB1 (Table 1, Figs. 1 C and 2 B). To determine
the fraction of ErbB1 that formed heteroclusters with ErbB2,
we labeled the former with acceptor-tagged antibodies and
the latter with donor-tagged antibodies. The fraction of het-
eroclustered ErbB1 in quiescent and EGF stimulated cells
was 40% and 33%, respectively (Table 1, Figs. 1 B and
2 B). The absolute number of free and bound (i.e., clustered)
ErbB1 and ErbB2 was also calculated using the expressionTABLE 1 The numbers and fractions of free and heteroclustered E
ErbB1 Free or homoclustered
in complex
with ErbB2
ErbB2 Free or homoclustered
in complex
with ErbB1
The numbers and fractions of free (or homoclustered) and heteroclustered protein
dard errors of the percentage of heteroclustered molecules determined from ~100
to those of free/homoclustered molecules since the latter was calculated by subt
Biophysical Journal 99(1) 105–114levels of the proteins determined by flow cytometry (Table
1 and Table S1). The term ‘‘free acceptor’’ means that the
acceptor is not heteroassociated with the donor, but they
may form homoclusters or associate with other molecules
in the membrane.
The fraction of heterocluster-forming ErbB2 was also
analyzed on a cell-by-cell basis, and was found to be inde-
pendent of the expression levels of ErbB1 and ErbB2
(Fig. S5 A). To the contrary, the FRET efficiency was
proportional to the acceptor/donor ratio (Fig. S5 B). If free
and bound ErbB2 were in equilibrium according to the law
of mass action, the fraction of heteroassociating ErbB2
would depend on the expression levels of ErbB1 and ErbB2
(Fig. S5 C). The fact that the fraction of bound ErbB2 wasrbB1 and ErbB2 in control and EGF-stimulated SKBR-3 cells
Quiescent (103) EGF stimulation (103)
1205 8 (605 4%) 1345 10 (675 5%)
805 8 (405 4%) 665 10 (335 5%)
10805 24 (905 2%) 9485 36 (795 3%)
1205 24 (105 2%) 2525 36 (215 3%)
s were determined by FSAB as described in the legend to Fig. 2 B. The stan-
cells in three independent experiments are also shown. These errors are equal
racting the percentage of heteroclustered molecules from 100%.
FSAB Reveals Coclustering of ErbB1 and ErbB2 111independent of the expression levels of ErbB1 and ErbB2
implies that the formation of these heteroclusters does not
follow the law of mass action.DISCUSSION
In this work, we report the successful implementation of the
FSAB technique to measure the heteroclustering of membrane
proteins in a quantitative way. The approach is based on pref-
erential, FRET-induced bleaching of photolabile acceptors in
the molecular proximity of photostable donors. Although both
donor bleaching and direct bleaching of the acceptor take
place, they do not compromise the reliability of the approach,
and we concluded that AlexaFluor546 and Cy5 are a suitable
donor-acceptor pair, since bound acceptors are indeed prefer-
entially bleached (Fig. S3). The photophysics of Cy5 is
complicated and involves cis-trans isomerization, reversible
photoinduced transition between dark and bright states, triplet
and higher excited states, and interaction between neighboring
fluorophores (24,29–31). In the absence of oxygen and CBr4,
Cy5 emits 100,000–200,000 photons before irreversible pho-
tobleaching occurs (30,32). The presence of oxygen, the short
lifetime and large molar absorption coefficient, and the conse-
quent rapid cycling between the ground and excited states
deteriorates the photostability of Cy5 in confocal microscopy
(33). CBr4 substantially decreases the photostability of Cy5
by photoinduced electron transfer (22) without significantly
accelerating the rate of AlexaFluor546 bleaching (Fig. S1).
Because of their photostability, quantum dots would have
been the best choice for the photostable donor, but the rate
of their bleaching was significantly increased by CBr4
(Fig. S1). We also considered AlexaFluor555 as a potential
donor for Cy5 in the FSAB experiments. Based on its photo-
bleaching quantum yield, AlexaFluor555 is ~10 times more
photostable than AlexaFluor546 (34). In certain cases, Alexa-
Fluor555 may be a suitable dye for FSAB experiments, but its
low fluorescence quantum yield and the small R0 for the
Alexa-Fluor555-Cy5 pair (R0,A555-Cy5 ¼ 4.9 nm, R0,A546-Cy5
¼ 6.8 nm) limit its applicability.
Transient, photoinduced dark states of Cy5 can invalidate
the interpretation of FRET experiments involving Cy5 as an
acceptor (31). However, the bleaching curves of Cy5 re-
ported here represent irreversible photobleaching, since illu-
mination at 543 nm did not recover the fluorescence intensity
(data not shown). Contrary to the findings of Eggeling et al.
(29), who reported accelerated photobleaching of Cy5 with
excitation in the short-wavelength range of the absorption
spectrum, we observed partial bleaching of Cy5 with illumi-
nation at 543 nm (Fig. S2 A). We do not know the reason for
this observation. The ratios of fluorescence intensities
excited at 543 and 633 nm were identical before and after
photobleaching at 543 nm. In addition, the emission spectra
of Cy5 bleached at 543 nm and that of unbleached Cy5 were
identical (Fig. S2 B). These findings exclude the possibility
that molecules that differed in their ground-state excitationspectrum led to the observation. Either the photobleaching
illumination at 543 nm reacts differently compared to the
633 nm light with the homogeneous population of molecules
(and does not bleach them completely), or the subpopulation
of molecules that display different photosensitivities at 543
and 633 nm have identical excitation spectra. Interaction
between Cy5 molecules conjugated to the same IgG is
unlikely to be behind the observations, since such interac-
tions were reported to take place only if the number of
Cy5 labels per IgG is >2–3 (24). Heterogeneous photo-
bleaching of Cy5 was detected previously and assumed to
be caused by heterogeneity of Cy5 generated during protein
labeling or by impurities in the dye (30). Although photo-
bleaching of Cy5 carried out at 543 nm was partial, FRET-
induced bleaching of Cy5 was complete (Fig. 1). The reason
for this finding is also obscure. If the FRET-induced bleach-
ing had been incomplete, it should have been taken into
consideration by Eq. 6.
Heteroclusters can be analyzed by several biophysical
methods. Fluorescence correlation spectroscopy has been
applied in confocal microscopy to study the dynamics of
molecules (35). Fluorescence cross-correlation spectroscopy
(19,36), cross-correlation raster image spectroscopy (21),
and two-color N&B analysis (20) report the stoichiometry
of stable molecular heteroassociations. Although homo-
FRET is sensitive to the size of protein clusters, it can only
be used for the analysis of homoassociations (17,18).
Although conventional hetero-FRET measurements do not
usually provide information about the stoichiometry of clus-
ters or the fraction of clustered molecules, several FRET-
based methods have been put forward to obtain these kinds
of information. A systematic analysis of the dependence of
FRET efficiency on the local density of acceptors allowed
investigators to determine an upper bound for the percentage
of clustered GPI-anchored proteins (37). A lower-bound
value for the fraction of clustered donor molecules was ob-
tained by comparing the photobleaching kinetics of the
donor in the absence and presence of an acceptor (28,38).
Dual measurements of the kinetics of donor bleaching in
the donor and FRET channels enabled Clayton et al. (38)
to calculate the fraction of donors undergoing FRET. Hoppe
et al. (39) reported that the stoichiometry of CFP-citrine
complexes can be determined provided that the FRET effi-
ciency of a bound donor-acceptor pair is known. FSAB pres-
ents an alternative method for determining the fraction of
heteroclustered acceptors without requiring sophisticated
technologies or complex image processing.
The methods used to characterize molecular associations
have different sensitivities for detecting clusters that differ
in size and stability (40). Since the FSAB approach is based
on hetero-FRET, it has all the inherent advantages and limi-
tations of the hetero-FRET principle. Alterations in FRET
efficiency can be caused by changes in the orientation or
distance between the donor and the acceptor (27). Due to
the flexibility of the chemical linkage between theBiophysical Journal 99(1) 105–114
FIGURE 4 Clustering of membrane proteins revealed by FSAB. (A) Het-
eroclusters contain a mixture of donor- and acceptor-tagged antibodies.
Multiple acceptors surrounding a donor molecule take part in FSAB interac-
tions. All such acceptors in the immediate vicinity of donors will be photo-
bleached. (B) A mixture of homo- and heteroclusters and free (unclustered)
receptors exists in unstimulated SKBR-3 cells. The majority of ErbB1 is not
involved in heteroclusters with ErbB2. According to our previous work (18),
most of these ErbB1 molecules are monomeric. The overwhelming majority
of ErbB2 is outside ErbB1-2 heteroclusters and forms large-scale homoclus-
ters (18). Upon EGF stimulation, ErbB2 is recruited from ErbB2 homoclus-
ters to form heteroclusters with ErbB1, leading to a decrease in the homo-
cluster size of ErbB2 and an increase in the fraction of heteroclustered
ErbB2. At the same time, the size of the ErbB1 homoclusters increases
because EGF induces the formation of ErbB1 homoaggregates in addition
to ErbB1-2 heteroclusters. Due to the opposing effects of homo- and heter-
odimerization, the fraction of heteroclustered ErbB1 does not substantially
change upon EGF stimulation. The percentages of homo- and heteroclus-
tered ErbB proteins are expected to be cell-type-dependent, but the general
tendency depicted in the figure is likely to be valid for cells overexpressing
ErbB2 with a moderate expression level of ErbB1.
112 Szabo´ et al.antibodies and the fluorophores, dynamic averaging of the
orientation factor takes place, eliminating the dependence
of FRET on orientation. It was also recently shown that
although fixation is expected to restrict the rotational
mobility of proteins, intermolecular FRET efficiencies are
not significantly affected by fixation (41). The sensitivity
of the FSAB approach for detecting clusters with different
sizes and stabilities also has to be discussed. Steady-state
FRET measurements cannot discriminate between dimers
(two molecules bound to each other by specific molecular
interactions) and the proximity of two molecules as a result
of accidental apposition (random association due to high
density) or partitioning into the same microdomain (co-
confinement). Such discrimination would require an anal-
ysis of the dependence of FRET on the donor/acceptor ratio
or the acceptor density (42). Consequently, FSAB measure-
ments simply reveal the fraction of acceptors within FRET
distance of the donors. In addition to dimers and small-scale
clusters, aggregation of proteins on a much larger scale has
been identified (16,18). Some acceptors in such clusters
may be beyond the FRET distance from donors, especially
if they outnumber the donor-labeled protein. Although these
large-scale clusters are dynamic (43), because of the
restricted lateral mobility of proteins in fixed cells, these
distant acceptors are not reached by donors. Consequently,
the contribution of large-scale clusters to the fraction of
bleached acceptors is underestimated in FSAB measure-
ments.
We applied the FSAB technique to investigate hetero-
clustering of ErbB1 and ErbB2. Almost half of ErbB1 is
heteroclustered with ErbB2 in quiescent cells, whereas
only ~10% of ErbB2 is in heteroclusters with ErbB1 (Table
1 and Table S1). The fact that the majority of ErbB2 is not
heteroclustered with ErbB1 reflects the much greater
numbers of ErbB2 expressed by SKBR-3 cells and the
strong tendency of ErbB2 to form homoclusters (Fig. 4 B)
(18). After EGF treatment, the fraction of heteroclustered
ErbB1 did not change significantly, because EGF induces
the formation of both ErbB1 homodimers and ErbB1-2 het-
erodimers. ErbB2 behaved in a different way. EGF induced
an increase in the fraction of ErbB2 in heteroclusters with
ErbB1. We previously reported that the size of ErbB2
homoclusters decreases after EGF stimulation (18). We
assumed that this phenomenon is caused by ErbB2 being
removed from its homoclusters due to recruitment into
ErbB1-2 heteroclusters. Our current findings corroborate
this hypothesis, as summarized in Fig. 4 B. According to
the model, large-scale homoclusters of ErbB2 are partially
disrupted after EGF stimulation. ErbB2 homoclusters
contain inactive ErbB2, providing a pool for recruitment
into heteroclusters with other ErbB proteins. Xiao et al.
(44) reached a similar conclusion in a recent study. They
found that the lateral diffusion coefficient and the size of
the confinement zone of ErbB2 increased upon heregulin
stimulation. Although they concluded that the observedBiophysical Journal 99(1) 105–114changes were caused by cytoskeletal interactions, a decrease
in the size of ErbB2 homoclusters is also expected to lead to
the same effects.
We found the fraction of heteroclustered ErbB2 to be inde-
pendent of the expression levels of ErbB1 and ErbB2 when
analyzed at the level of single cells (Fig. S5). This observa-
tion implies that the formation of clusters detected by FSAB
is not governed by the law of mass action. We believe that
the composition of these clusters is established during their
export by the vesicular transport system to the cell
membrane, and that the density of proteins in the membrane
of these vesicles is more or less constant and independent of
the number of proteins expressed in the cell membrane.
In conclusion, we have demonstrated that the FSAB tech-
nique can be applied to determine the fraction of heteroclus-
tered molecules in a quantitative way, and to investigate the
FSAB Reveals Coclustering of ErbB1 and ErbB2 113composition of ErbB1-2 heteroclusters. Our interpretation of
the experimental findings is in agreement with our previous
results and suggests that the size of large-scale ErbB2 clus-
ters decreases upon EGF stimulation. FSAB and other quan-
titative methods are required to shed light on the intricate
details of the first steps of activation of the ErbB receptor
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